How early-stage investors evaluate your startup​

How early stage investors assess a startup

Across pre-seed, seed and Series A, I see the same patterns again and again. Different funds, different cheques, but very similar thinking. In practice, investors are trying to understand eight core areas when they look at your opportunity. Once you understand those eight areas, the way you talk about your business – and the way you build your deck – changes completely.

Pre-Seed in 2026: Why ideas don’t raise investment anymore

Fundraising in 2026

The myth that pre-seed is still about raising money for an idea lingers on. It used to be true, but the ground has shifted. Investors are no longer betting on potential alone. They’re looking for proof that a founder can turn an idea into something real. That shift has caught a lot of founders off guard.

Three things to stop saying in investor pitches

Three things to stop saying when you pitch

Founders rarely realise how much damage a single sentence can do in a pitch. I see the same lines repeated in meeting after meeting, usually delivered with confidence, as if they’re an expected part of the script. They aren’t. They’ve simply been copied from other founders who also didn’t know better.

What makes a great investor pitch deck?

what makes a great pitch deck?

Founders often ask me what makes a great investor pitch deck, and the truth is far less complicated than they expect. I see the same patterns play out over and over again. The moments when an investor leans forward. The moments when they glaze over. And the moments when they decide – often within seconds – whether the founder in front of them is someone they want to back.

Investors don’t invest in ideas. They invest in evidence

Investors don't invest in ideas

Every week I meet founders who believe the strength of their idea will carry them through a fundraise. They walk into investor meetings armed with vision, ambition and promise. What they don’t have is the one thing investors actually buy into. Evidence. The gap between those two things is where most early-stage fundraising attempts collapse.

Are you building a vitamin or a painkiller?

Startup positioning - painkiller or vitamin pill

When I speak with founders about their product, most can clearly describe the problem they solve. What’s often missing is how they frame that solution — not just as something that adds value, but as something that genuinely removes pain. The way you frame your proposition determines whether investors see it as essential or optional – as a painkiller, or a vitamin.